SAN FRANCISCO, January 8, 2024 — Caresyntax, the leading vendor-neutral surgical data and intelligence platform converging AI-powered software, devices, and clinical services, today announced the launch of Caresyntax Clinical Data as a Service (CDaaS) for Medtech industry partners.
The launch of Caresyntax CDaaS follows the recently announced addition of CQInsights (CQI) and appointment of Dr. Bruce Ramshaw as Chief Medical Informatics Officer (CMIO) for Caresyntax. The integration of the CQI solution into the Caresyntax platform enables a stack of technologies and capabilities with new digital workflows that can acquire curated data and return insights throughout the surgical experience. This offering presents unparalleled opportunity for data enrichment and insight for medical device industry partners.
“The ability to capture and deliver data insights across the entire cycle of care presents a new avenue for partners to measure value and improve outcomes with a data-first approach. By adding proven methodologies like Dr. Ramshaw’s to our centralized surgical intelligence platform, and with our constantly evolving suite of tech catalysts, we can help usher in a new era of surgical data science with measurable value for all players in the space: health systems, clinicians, payors, and now MedTechs,” Dennis Kogan, CEO of Caresyntax.
Caresyntax CDaaS helps partners overcome the opacity that surrounds the patient experience in the OR. While modern electronic medical records (EMR) and data warehouses provide insight to high level data like demographics, billing, and reimbursement claims, there is less discrete data output from the actual OR experience. With Caresyntax’ fully developed, vendor-neutral data ingestion platform and the integrated methodologies like the CQI solution, CDaaS offers industry partners the opportunity to capture rich information across a broad range of modalities including EMR, web and mobile applications, video, telepresence, network integration, and unique OR edge-deployed applications. With curated data from the entire surgical care process, Medtech industry partners gain meaningful insight into the critical factors that can affect outcomes and improve clinical quality for patients. This data also provides tremendous value back to hospital partners and clinicians as Caresyntax provides data science reporting and analysis back to hospitals for their value analysis, product evaluation, and value-based care initiatives.
“Caresyntax Clinical Data as a Service represents the next step of the Caresyntax journey, as we continue to unlock data from the surgical suite. The clinical quality improvement methodology is proven to help improve clinical outcomes while also increasing profitability and quality. We are excited to offer Clinical Data as a Service to all our industry and provider partners,” said Dr. Ramshaw.
Caresyntax now offers proven and scalable capabilities for industry partners to grow revenue, measure and improve value, and inform product development through data. Some of the benefits already realized by clients include market share capture and extension, submission to post market regulatory processes, new and expanded indications, removal of contraindications, quantifiable impact for value analysis committees, and data-informed product development and portfolio planning.
Caresyntax CDaaS offers contextual data collection that is unmatched by current players, lower costs compared to traditional research organizations, and shortened timelines compared to in-house data collection teams. In addition, partners benefit with access to the Caresyntax worldwide network of hospitals and key opinion leaders, with users in over 3,000 operating rooms spanning academic, national/federal, nonprofit, private, and tertiary/rural hospital sites.
About Caresyntax
Caresyntax is on a mission to make surgery smarter and safer by converging AI-powered software, devices, and clinical services to help customers improve surgical outcomes. Our vendor neutral, enterprise-grade surgical intelligence platform delivers actionable insights to improve patient outcomes by using proprietary software and artificial intelligence (AI) to analyze large volumes of video, audio, images, device data, clinical and operational data in and around the OR. This real-world evidence can be used by the care team live, during a procedure and accessed by those outside the operating room via the platform’s dedicated telehealth link. After a procedure, the Caresyntax platform provides insights that help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. Headquartered in the US in San Francisco and internationally in Berlin, Caresyntax software is used in more than 2,800 operating rooms worldwide and supports surgical teams in over two million procedures per year. For more information, visit us at Caresyntax.com
Caresyntax Contact:
CDaaS for Medtech